Advanced generation of paeonol-phenylsufonyl derivatives as potential anti-HBV agents

被引：8
|
作者：
Huang, Y. P. [1 ]
Shih, H. P. [1 ]
Liang, Y. C. [2 ]
Lin, H. H. [3 ]
Lin, M. C. [4 ]
Chen, C. W. [5 ,6 ]
Huang, T. J. [7 ]
Kuo, Y. C. [8 ]
Han, C. C. [1 ]
Hsu, M. H. [9 ,10 ]
机构：
[1] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan
[2] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan
[3] Taipei Vet Gen Hosp, Dept Oncol, Div Radiotherapy, Taipei 115, Taiwan
[4] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu 30013, Taiwan
[5] China Med Univ Hosp, Dept Anesthesiol, Taichung 404, Taiwan
[6] China Med Univ, Sch Med, Dept Anesthesiol, Taichung 404, Taiwan
[7] China Med Univ, Sch Med, Taichung 404, Taiwan
[8] Show Chwan Mem Hosp, Radiat Oncol, Changhua 50008, Taiwan
[9] Natl Tsing Hua Univ, Nucl Sci Technol Dept Ctr, Hsinchu 30013, Taiwan
[10] Tamkang Univ, Dept Chem, New Taipei 25137, Taiwan
来源：
RSC ADVANCES | 2016年 / 6卷 / 49期
关键词：
HEPATITIS-B; DISCOVERY; DESIGN;
D O I：
10.1039/c6ra06119b
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Hepatitis B virus (HBV) infection causes serious liver diseases, and the development of effective drugs for chronic hepatitis B treatment remains an important step towards the eradication of HBV worldwide. Recently, our group designed paeonol-phenylsulfonyl derivatives and found that the compound 2-acetyl-5-methoxyphenyl 4-methoxybenzenesulfonate (6f) had the most potent antiviral effect against HBV, with an IC50 value of 0.36 mu M and a high selectivity index (SI; TC50/IC50) of 47.75. In this research, we modified compound 6f with a 2-aminothiazole scaffold and generated 13 novel paeonol derivatives by utilizing various benzoyl and acyl chlorides. Among this new generation, compound 2-(2-benzamidothiazol-4-yl)-5-methoxyphenyl 4-methoxybenzenesulfonate (8a) showed the highest SI value of 59.14 which exceeds those of compound 6f and lamivudine (3TC), a commercially available antiviral drug. Hence, we believe that our studies may offer some useful information for the development of antiviral medicines.
引用
收藏
页码：43556 / 43562
页数：7
相关论文
共 50 条
  • [41] In vitro susceptibility of HBV polymerase encoding mutations acquired during adefovir dipivoxil therapy to other anti-HBV agents
    Qi, Xiaoping
    Xiong, Shelly
    Yang, Huiling
    Miller, Michael D.
    Delaney, William
    HEPATOLOGY, 2006, 44 (04) : 252A - 253A
  • [42] The hepatitis B virus-trimera mouse: A model for human HBV infection and evaluation of Anti-HBV therapeutic agents
    Ilan, E
    Burakova, T
    Dagan, S
    Nussbaum, O
    Lubin, I
    Eren, R
    Ben-Moshe, O
    Arazi, J
    Berr, S
    Neville, L
    Yuen, L
    Mansour, TS
    Gillard, J
    Eid, A
    Jurim, O
    Shouval, D
    Reisner, Y
    Galun, E
    HEPATOLOGY, 1999, 29 (02) : 553 - 562
  • [43] Design, synthesis and anti-HBV activity of novel bis(trifluoroethyl)phosphonomethyl ether derivatives of acyclovir
    Lu, Peng
    Jiang, Sai Hong
    Liu, Jiang Xia
    Yang, Yu She
    Ji, Ru Yun
    CHINESE CHEMICAL LETTERS, 2009, 20 (05) : 507 - 510
  • [44] Non-nucleoside anti-HBV agents: advances in structural optimization and mechanism of action investigations
    Liu, Na
    Zhao, Fabao
    Jia, Haiyong
    Rai, Diwakar
    Zhan, Peng
    Jiang, Xuemei
    Liu, Xinyong
    MEDCHEMCOMM, 2015, 6 (04) : 521 - 535
  • [45] Screening and identification of potential targets for Anti-HBV drugs in HepG2.2.15 cells
    Yang, Jing
    Bo, Xiao-chen
    Zhang, Min-li
    Wang, Sheng-qi
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (10) : S200 - S200
  • [46] Design,synthesis and anti-HBV activity of novel bis(trifluoroethyl)phosphonomethyl ether derivatives of acyclovir
    Peng Lu~a
    Chinese Chemical Letters, 2009, 20 (05) : 507 - 510
  • [47] Synthesis and Evaluation of Paeonol Derivatives as Potential Multifunctional Agents for the Treatment of Alzheimer's Disease
    Zhou, An
    Wu, Hongfei
    Pan, Jian
    Wang, Xuncui
    Li, Jiaming
    Wu, Zeyu
    Hui, Ailing
    MOLECULES, 2015, 20 (01) : 1304 - 1318
  • [48] Asymmetric synthesis of amino-substituted apio dideoxynucleosides as potential anti-HBV agent.
    Jeong, LS
    Choi, WJ
    Ahn, HS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : B186 - B186
  • [49] STRUCTURE-ACTIVITY-RELATIONSHIPS OF ENANTIOMERICALLY PURE D-OXATHIOLANE-NUCLEOSIDES AND L-OXATHIOLANE-NUCLEOSIDES AS POTENTIAL ANTI-HIV AND ANTI-HBV AGENTS
    JEONG, LS
    BEACH, JW
    KIM, HO
    NAMPALLI, S
    SHANMUGANATHAN, K
    SCHINAZI, RF
    CHANG, CN
    CHENG, YC
    CHU, CK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 20 - CARB
  • [50] Structure-activity relationships of 2'-fluoro-L-pyrimidine nucleosides as anti-HBV agents.
    Ma, T
    Pai, SB
    Zhu, YL
    Lin, JS
    Cheng, YC
    Chu, CK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 69 - CARB
12345